Panacos Pharmaceuticals panacos.com


Public lists: Pharma Startups (4732)

Panacos is developing anti-infective products through discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Per the company, Panacos' proprietary discovery technologies are designed to combat resistance by focusing on novel targets in the virus life cycle, including virus maturation and virus fusion.

Panacos is developing anti-infective products through discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Per the company, Panacos' proprietary discovery technologies are designed to...Show all

Company (Alive / Active)

Phone: 617-926-1551

Fax:

134 Coolidge Avenue

Watertown, 02472
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Panacos Pharmaceuticals $51.6M Oct 18, 2007
Humanetics Corporation $0.6M Oct 10, 2017
GeoVax $0M Nov 29, 2018
See all 27 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Panacos Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 16 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 27 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein May 24, 2004 May 26, 2009 Patent